Article ISI
Frontier in Immunology  (2016)

Treatment with Dexamethasone and Monophosphoryl Lipid A Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers Tolerogenic Features.

García-González, PA; Schinnerling, K; Sepúlveda-Gutiérrez, A; Maggi, J; Hoyos, L; Morales, RA; Mehdi, AM; Nel, HJ; Soto, L; Pesce, B; Molina, MC; Cuchacovich, M; Larrondo, ML; Neira, Ó; Catalán, DF; Hilkens, CM; Thomas, R; Verdugo, RA; Aguilón, JC